US FDA approves Stivarga for advanced GIST
GIST is a tumour in which cancerous cells form in the tissues of the gastrointestinal tract, part of the body’s digestive system
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
New age nutra sutra
The nutraceutical segment of the women health market is poised to see high growth, as consumers seem ready to try novel…
Industry unhappy with draft glines for traditional knowledge patents
To submit representation to Indian Patent office before March 15, 2013
Biocon enhances partnership with Mylan for insulin products
Mylan and Biocon will share development, capital and certain other costs to bring the products to market
Aurobindo Pharma receives US FDA approvals
Pioglitazone and Pioglitazone Hydrochloride + Metformin Hydrochloride tabs are ready for launch
Sun Pharma and Taro announce termination of proposed transaction
Termination was in best interest of respective companies and shareholders
Sanofi India launches Combiflam Plus
The launch of this new product marks the company’s foray into the OTC headache segment in India
GGEl launches first generic Atovaquone Proguanil in the UK
Launch follows the revocation of the Malarone patent in the High court in the UK
Pharmexcil to open warehouse facility in Nigeria
To provide subsidised facilities to all its members
IPM grows at 9.8 per cent in January 2013
From a therapy perspective 11 therapies have outgrown the IPM growth